Targeting GOLPH3L improves glioblastoma radiotherapy by regulating STING-NLRP3–mediated tumor immune microenvironment reprogrammingShuo Sun, Hong Xiao, Wei Gu et al.|Science Translational Medicine|2025Cited by 18